Covered recipient · General Payments record
NADINE J BEDROSIAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Surgical
General Payments · PY2021–2024
$1,328.27
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.16 | 15 |
| Education | $198.99 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $248.01 | 9 |
| Janssen Biotech, Inc. | $99.99 | 1 |
| Incyte Corporation | $99.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $51.51 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.85 | 2 |
| Arcutis Biotherapeutics, Inc. | $14.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.10 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505005 | CMS |
| ABBVIE INC. | $28.81 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505007 | CMS |
| ABBVIE INC. | $18.77 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505009 | CMS |
| ABBVIE INC. | $27.15 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505011 | CMS |
| ABBVIE INC. | $17.22 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505013 | CMS |
| ABBVIE INC. | $8.81 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505015 | CMS |
| ABBVIE INC. | $16.95 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505017 | CMS |
| ABBVIE INC. | $28.15 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505019 | CMS |
| ABBVIE INC. | $87.05 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106505021 | CMS |
| Arcutis Biotherapeutics, Inc. | $14.79 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121115053 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.71 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101215306 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.81 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101215318 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.99 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101215362 | CMS |
| Incyte Corporation | $99.00 | 01/28/2024 | Education | Undisputed | 01/23/2026 | 1141298467 | CMS |
| Janssen Biotech, Inc. | $99.99 | 04/11/2024 | Education | Undisputed | 01/23/2026 | 1078411344 | CMS |
| Novartis Pharmaceuticals Corporation | $21.29 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086726911 | CMS |
| Novartis Pharmaceuticals Corporation | $19.56 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086726925 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.